Açaí Berries Inhibit Colon Tumorigenesis in Azoxymethane/Dextran Sulfate Sodium-Treated Mice
Gut and Liver
; : 243-252, 2017.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-69995
Responsible library:
WPRO
ABSTRACT
BACKGROUND/AIMS:
The aim of this study was to investigate the protective effect of açaí against azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colorectal cancer development.METHODS:
The effect of açaí on tumorigenesis was assessed by evaluating tumor incidence, multiplicity and invasiveness in the mouse colon. The levels of myeloperoxidase (MPO) and proinflammatory cytokines (tumor necrosis factor α [TNF-α], interleukin [IL]-1β, and IL-6) were measured via enzyme-linked immunosorbent assay. Protein levels of cyclooxygenase 2 (COX-2), proliferating cell nuclear antigen (PCNA), B-cell lymphoma 2 (Bcl-2), Bcl-2-associated death promoter (Bad) and cleaved-caspase-3 were assessed by immunoblotting.RESULTS:
Administration of pellets containing 5% açaí powder reduced the incidences of both colonic adenoma and cancer (adenoma, 23.1% vs 76.9%, respectively, p=0.006; cancer, 15.4% vs 76.9%, respectively, p=0.002). In the açaí-treated mice, the MPO, TNF-α, IL-1β and IL-6 levels in the colon were significantly down-regulated. Açaí inhibited PCNA and Bcl-2 expression and increased Bad and cleaved-caspase-3 expression. In vitro studies demonstrated that açaí treatment reduced lipopolysaccharide-induced expression of TNF-α, IL-1β, IL-6 and COX-2 in murine macrophage RAW 264.7 cells.CONCLUSIONS:
Açaí demonstrated protective effects against AOM/DSS-induced colon carcinogenesis, which suggests that the intake of açaí may be beneficial for the prevention of human colon cancer.
Full text:
Available
Health context:
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
Health problem:
Colon and Rectum Cancers
/
Lymphomas and Multiple Myeloma
Database:
WPRIM (Western Pacific)
Main subject:
Sodium
/
Azoxymethane
/
In Vitro Techniques
/
Enzyme-Linked Immunosorbent Assay
/
Colorectal Neoplasms
/
Immunoblotting
/
Adenoma
/
Incidence
/
Cytokines
/
Lymphoma, B-Cell
Type of study:
Incidence study
/
Prognostic study
Limits:
Animals
/
Humans
Language:
English
Journal:
Gut and Liver
Year:
2017
Document type:
Article